Patients with severe disease show lower levels of CD4+ and CD8+ T cells and higher levels of pro-inflammatory plasma IL-6 compared with patients with mild illness, associated with reduced patient survival, highlighting the important role of this immune mediator in the pathogenesis and COVID-19 severity (12). This evidence concerns the gene IL6 and COVID-19.